Literature DB >> 26938921

A decision-making tool for exchange transfusions in infants with severe hyperbilirubinemia in resource-limited settings.

B O Olusanya1, I F Iskander2, T M Slusher3, R P Wennberg4.   

Abstract

Late presentation and ineffective phototherapy account for excessive rates of avoidable exchange transfusions (ETs) in many low- and middle-income countries. Several system-based constraints sometimes limit the ability to provide timely ETs for all infants at risk of kernicterus, thus necessitating a treatment triage to optimize available resources. This article proposes a practical priority-setting model for term and near-term infants requiring ET after the first 48 h of life. The proposed model combines plasma/serum bilirubin estimation, clinical signs of acute bilirubin encephalopathy and neurotoxicity risk factors for predicting the risk of kernicterus based on available evidence in the literature.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26938921     DOI: 10.1038/jp.2016.25

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  33 in total

Review 1.  Vigintiphobia revisited.

Authors:  Jon F Watchko
Journal:  Pediatrics       Date:  2005-06       Impact factor: 7.124

Review 2.  Neonatal hyperbilirubinemia and kernicterus - not gone but sometimes forgotten.

Authors:  M Jeffrey Maisels
Journal:  Early Hum Dev       Date:  2009-11       Impact factor: 2.079

3.  Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia.

Authors:  Rasha Gamaleldin; Iman Iskander; Iman Seoud; Hanan Aboraya; Aleksandr Aravkin; Paul D Sampson; Richard P Wennberg
Journal:  Pediatrics       Date:  2011-09-12       Impact factor: 7.124

Review 4.  Chronic bilirubin encephalopathy: diagnosis and outcome.

Authors:  Steven M Shapiro
Journal:  Semin Fetal Neonatal Med       Date:  2010-01-29       Impact factor: 3.926

5.  Follow-up of extreme neonatal hyperbilirubinaemia in 5- to 10-year-old children: a Danish population-based study.

Authors:  Pernille Kure Vandborg; Bo Moelholm Hansen; Gorm Greisen; Rene Mathiasen; Frederikke Kasper; Finn Ebbesen
Journal:  Dev Med Child Neurol       Date:  2014-10-29       Impact factor: 5.449

Review 6.  Kernicterus: epidemiological strategies for its prevention through systems-based approaches.

Authors:  Vinod K Bhutani; Lois H Johnson; M Jeffrey Maisels; Thomas B Newman; Ciaran Phibbs; Ann R Stark; Marshalyn Yeargin-Allsopp
Journal:  J Perinatol       Date:  2004-10       Impact factor: 2.521

7.  Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns.

Authors:  Michael W Kuzniewicz; Andrea C Wickremasinghe; Yvonne W Wu; Charles E McCulloch; Eileen M Walsh; Soora Wi; Thomas B Newman
Journal:  Pediatrics       Date:  2014-08-04       Impact factor: 7.124

Review 8.  Revisiting the Criteria for Exchange Transfusion for Severe Neonatal Hyperbilirubinemia in Resource-Limited Settings.

Authors:  Bolajoko O Olusanya; Zainab O Imam; Abieyuwa A Emokpae; Iman F Iskander
Journal:  Neonatology       Date:  2015-11-24       Impact factor: 4.035

9.  Outcomes in a population of healthy term and near-term infants with serum bilirubin levels of >or=325 micromol/L (>or=19 mg/dL) who were born in Nova Scotia, Canada, between 1994 and 2000.

Authors:  Krista A Jangaard; Deshayne B Fell; Linda Dodds; Alexander C Allen
Journal:  Pediatrics       Date:  2008-07       Impact factor: 7.124

10.  Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings.

Authors:  Bolajoko O Olusanya; Tinuade A Ogunlesi; Praveen Kumar; Nem-Yun Boo; Iman F Iskander; Maria Fernanda B de Almeida; Yvonne E Vaucher; Tina M Slusher
Journal:  BMC Pediatr       Date:  2015-04-12       Impact factor: 2.125

View more
  2 in total

1.  A neurologic dysfunction scoring protocol for jaundiced neonates requiring exchange transfusion.

Authors:  Bolajoko O Olusanya; Folashade B Osibanjo; Adeniyi A Ajiboye; Oluwafemi E Ayodele; Adebanke A Odunsi; Serah M Olaifa; Abieyuwa A Emokpae
Journal:  J Matern Fetal Neonatal Med       Date:  2017-03-20

2.  An analysis on treatment effect of blue light phototherapy combined with Bifico in treating neonatal hemolytic jaundice.

Authors:  Yan Jiao; Yuting Jin; Huanhuan Meng; Meizhang Wen
Journal:  Exp Ther Med       Date:  2018-06-21       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.